Tsubota Laboratory Incorporated
4890.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.37 | 0.02 | -4.93 | -5.11 |
| FCF Yield | -3.29% | -3.52% | -0.10% | 3.03% |
| EV / EBITDA | 27.78 | -11.84 | 99.83 | 75.76 |
| Quality | ||||
| ROIC | 10.35% | -43.77% | 5.00% | 10.66% |
| Gross Margin | 86.72% | 3.17% | 75.33% | 86.91% |
| Cash Conversion Ratio | -1.54 | 0.47 | 0.32 | 4.28 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.44% | 1.67% | 11.57% | 13.27% |
| Free Cash Flow Growth | -5.87% | -1,446.19% | -103.48% | 6,855.00% |
| Safety | ||||
| Net Debt / EBITDA | -4.66 | 2.93 | -10.98 | -3.95 |
| Interest Coverage | 218.48 | -646.32 | 214.69 | 132.59 |
| Efficiency | ||||
| Inventory Turnover | 0.63 | 2.28 | 0.66 | 0.27 |
| Cash Conversion Cycle | 467.01 | 173.82 | 510.06 | 1,268.89 |